Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Amoxicillin + pantoprazole vs quadruple therapy for Helicobacter pylori eradication
IRCT20211019052812N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Nov 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of amoxicillin and pantoprazole in Helicobacter pylori infection (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: Helicobacter pylori eradication rate. Started Nov 2021; status: completed.
02
Drugs
amoxicillinpantoprazole
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on IRCT20211019052812N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20211019052812N1.